JEFFREY FRATTALI: Open Payments
NPI 1205927613 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,715 in 83 payments from 21 companies in 2025. Trend: 2023 $1,110 · 2024 $1,758 · 2025 $1,715
Food & beverage: $1,715
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $262 |
| Janssen Biotech, Inc. | 11 | $179 |
| Incyte Corporation | 8 | $158 |
| Organon LLC | 7 | $143 |
| Lilly USA, LLC | 4 | $109 |
| PFIZER INC. | 4 | $87 |
| GENZYME CORPORATION | 3 | $87 |
| Galderma Laboratories, L.P. | 4 | $82 |
| UCB, Inc. | 3 | $77 |
| Regeneron Healthcare Solutions, Inc. | 4 | $74 |
Products named: TREMFYA, DUPIXENT, OPZELURA, RINVOQ, SKYRIZI, TALTZ, Bimzelx, CIBINQO.
Industry payments across MD — which companies pay providers there.
